|Address:||16th Floor, Empire Heights Tower A, Business Bay, Dubai, UAE|
|Telephone:||+971 4 550 1800|
|Fax:||+971 4 453 4478|
2GIS is a free digital business listing platform with navigation. Our information on cities is always up to date.
2GIS came into existence in the year 1998 and has been operating in UAE since 2014.2GIS has grown significantly over the period of time in UAE and holds up to 40 million users globally that is across 9 countries and 316 cities.
2GIS is available on all the mobile application platforms for free and it also works offline.
|Stand No.:||15, 16|
|Address:||SCO.76,1st Floor,MDC, Swastik Vihar, Panchkula -134114(India)|
|Telephone:||+91 172 5022465|
|Fax:||+91 172 5022462|
CHERESO LIFESCIENCES, incorporated in 2003, is a company dedicated to the principles of tradition, innovation and research. The Company facility WHO-GMP, ISO 9001:2008, ISO 22000:2005, Kosher, HALAL and NSF- US GMP certified. Its business focuses on manufacturing of Nutraceuticals and standardized herbal extracts as per Pharmacopoeia Standards.
The company has expanded its business activities in countries like Asia, Africa, Europe, USA and other growing markets.
The company has also ventured into formulations and has given shape to various innovative products. Our product range includes FENFUROTM for blood glucose management, Furocyst® for management of PCOS, Grecobe® An ultimate antioxidant, Furoslim -Weight and Lipid Regulator, Chemforce -For Overall Energy and Vitality in men, Prosman, Supports Healthy Prostate and GCB-70 for Healthy Metabolism.
CHERESO has also recently entered the FMCG market with the launch of its product Grecobe as a beverage.
|Address:||Al Gulayaa, Sharjah, UAE|
|Telephone:||+971 6 506 5542|
|Fax:||+971 6 506 5502|
Shanab is a men’s health initiative that falls under Friends of Cancer Patients’ umbrella “Kashf” for early detection of cancer, addressing prostate cancer and testicular cancer. Launched in November 2014, Shanab; moustache in English, chiefly addresses testicular cancer and prostate cancer. It highlights the importance of early detection and endeavors to eliminate stigmas surrounding both types of cancer. Shanab aims at raising awareness among the target audience about the major health issues men face. It further encourages men to share their health concerns with their peers.
Being the most common type of cancer among young men (15-37 years), most of men are completely unaware of testicular cancer. Worldwide, there are 48,500 new patients diagnosed with testicular cancer each year; 8,900 of these men will die.
As for prostate cancer, it mainly occurs in older men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66. Both types of cancer are curable if detected at the early stages. Shanab, in light of this, stresses the significance of self-examination in detecting testicular cancer. Similarly, DRE (Digital Rectal Examination)/PSA (Prostate Specific Antigen) are two major exams for early detection of prostate cancer. Shanab seeks to collaborate with various government and private entities including health authorities, corporates, sporting associations and the like, in an attempt to maximise the scope of awareness and promote a culture where health comes before any other considerations.
|Address:||Airport Road, Digdaga, Ras Al Khaimah, United Arab Emirates|
|Telephone:||+971 7 246 1461|
|Fax:||+971 7 246 2462|
Established in 1980, Julphar is one of the largest pharmaceutical manufacturers in the Middle East and North Africa (MENA) region, producing over 200 branded products across its twelve manufacturing facilities. The Julphar mission is to offer high quality medicines at affordable prices, whilst also working towards positioning Ras Al Khaimah as a robust and growing market with a diversified economic base.
Julphar maintains a diverse product portfolio which target major therapeutic segments including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management.
Julphar’s core business is manufacturing and over the recent years decided to focus on innovation in Biotechnology with the launch of a $150m Manufacturing Facility entirely dedicated to producing Raw Material needed for Biosimilar products. Today, this facility is the only plant in the MENA region that produces insulin using insulin crystals derived from r-DNA technology.
|Address:||DHCC, Building 37, PO Box 505004|
|Telephone:||+971 4 435 9999|
|Fax:||+971 4 435 9900|
Mediclinic City Hospital is part of Mediclinic Middle East and wholly owned by Medwledge and expertise available in its 66 sister facilities in Southern Africa and Switzerland With 249 beds, Mediclinic City Hospital can accommodate patients with a wide range of individual health requirements. We offer specialist-focused treatment in the areas of cardiology, radiology, gynaecology, trauma, nuclear medicine, endocrinology , obstetrics, neonatal care and many others.
We offer advanced levels of diagnosis and treatment, ensuring every patient receives the highest levels of international-standard healthcare.
Mediclinic City Hospital has launched in 2016 its Comprehensive Cancer Centre (CCC), Dubai’s most advanced facility for the diagnosis and treatment of cancer. Built in collaboration with Mediclinic Middle East’s sister platform in Switzerland, Hirslanden, patients at the CCC will benefit from the sharing of knowledge and experience between some of the leading .
between some of the leading oncology experts in Europe and the Middle East, as well as access to the very latest treatment programmes and technology
|Address:||Sin El Fil 1-Habtoer Round about Marc 1 building 9th floor, Beirut, Lebanon|
Caring for the human being as a whole
In order to do this, we design and develop innovative solutions that contribute to people's well-being, from health to beauty. We achieve this by cooperating with health-care professionals, our trusted partners worldwide, by drawing relentless inspiration from nature and plants, and by placing pharmaceutical ethics at the very heart of our operations.
|Address:||Office 704, DSC Tower, Dubai Studio City, Dubai, UAE|
|Telephone:||+971 4 361 6399|
|Fax:||+971 4 4276652|
SOBI is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare diseases patients and their familiesnt in the MENA region that produces insulin using insulin crystals derived from r-DNA technology.